scanX
Home
Bajaj HealthCare

Bajaj HealthCare

385.95
-13.20
(-3.31%)
Market Cap (₹ Cr.)
₹1,103
52 Week High
513.40
Book Value
₹
52 Week Low
263.30
PE Ratio
35.58
PB Ratio
3.96
PE for Sector
39.11
PB for Sector
4.60
ROE
11.70 %
ROCE
20.70 %
Dividend Yield
0.25 %
EPS
₹10.38
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-0.95 %
Net Income Growth
-39.73 %
Cash Flow Change
-3,334.78 %
ROE
-46.16 %
ROCE
-34.69 %
EBITDA Margin (Avg.)
-8.73 %

Financial Results

Quarterly Financials
Dec 2015
Mar 2016
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
48
51
92
101
99
121
141
209
180
134
186
151
168
176
164
195
133
155
130
102
109
142
133
Expenses
43
42
83
92
86
99
114
174
134
98
152
122
137
151
142
166
108
140
163
91
97
162
109
EBITDA
5
9
9
9
13
23
26
34
46
37
34
29
31
26
23
30
25
15
-33
12
13
-20
24
Operating Profit %
11 %
17 %
10 %
9 %
13 %
17 %
18 %
16 %
25 %
26 %
18 %
19 %
18 %
14 %
14 %
15 %
19 %
9 %
-26 %
10 %
11 %
-21 %
18 %
Depreciation
2
3
3
3
3
3
4
4
4
4
4
4
5
4
4
4
4
5
6
7
7
7
7
Interest
2
2
2
2
2
1
2
2
2
2
3
3
3
4
3
4
5
6
9
8
7
6
8
Profit Before Tax
1
4
5
5
9
18
20
28
40
30
27
22
23
17
16
22
15
5
-48
-3
-1
-33
9
Tax
0
2
1
1
3
4
6
8
14
7
8
5
6
0
4
6
4
2
0
0
1
0
0
Net Profit
1
2
3
3
6
13
15
20
26
21
19
17
17
17
12
16
11
4
-48
-3
-2
-30
7
EPS in ₹
2.70
2.59
2.35
2.35
4.49
9.10
11.08
16.75
19.15
7.71
13.93
6.25
6.32
6.33
4.35
5.93
4.01
1.30
-17.47
-1.25
-0.80
-10.84
2.59
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
189
209
219
268
283
343
526
721
898
765
Fixed Assets
109
130
128
127
156
162
208
270
366
253
Current Assets
79
78
91
140
124
168
258
398
500
405
Capital Work in Progress
1
1
0
2
1
5
57
52
22
7
Investments
0
0
0
0
0
5
0
0
0
0
Other Assets
79
78
91
140
126
170
260
399
510
506
Total Liabilities
107
120
120
155
130
165
267
393
530
487
Current Liabilities
85
88
93
131
111
138
183
322
434
402
Non Current Liabilities
22
32
28
23
19
27
85
71
96
85
Total Equity
82
89
99
114
153
178
258
328
368
278
Reserve & Surplus
78
82
92
107
146
164
245
315
354
265
Share Capital
4
7
7
7
7
14
14
14
14
14
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Cash Flow
-0
-0
0
7
-0
-4
10
-12
16
Investing Activities
-17
-31
-8
-12
-13
-28
-109
-75
-93
Operating Activities
28
25
22
17
25
21
44
1
-22
Financing Activities
-11
5
-13
2
-13
3
75
62
132
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.30 %
67.30 %
67.42 %
67.49 %
67.49 %
67.69 %
67.73 %
67.73 %
67.73 %
FIIs
0.00 %
0.00 %
0.34 %
0.32 %
0.32 %
0.38 %
0.32 %
0.09 %
0.94 %
0.78 %
0.69 %
0.66 %
0.74 %
0.53 %
0.01 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.34 %
0.34 %
0.34 %
0.44 %
0.48 %
0.44 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
32.74 %
32.74 %
32.39 %
32.42 %
32.42 %
32.36 %
32.38 %
32.61 %
31.30 %
31.39 %
31.48 %
31.22 %
31.06 %
31.30 %
32.26 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,846.05 4,47,691.91 42.46 49,887.17 12.06 9,648 42.62 63.32
Cipla
1,637.70 1,34,956.56 30.36 26,520.66 14.17 4,155 17.77 55.49
Zydus Life Science
1,054.45 1,11,727.19 26.80 19,831.50 13.82 3,831 30.78 29.67
Dr Reddys Laboratories
6,502.55 1,10,648.92 19.88 28,905.40 12.36 5,578 -0.90 33.11
Lupin
2,171.90 1,03,570.56 45.76 20,141.50 19.94 1,936 77.69 50.58
Mankind Pharma
2,426.05 98,296.04 50.09 10,615.63 19.57 1,942 9.89 55.98
Aurobindo Pharma
1,528.10 90,940.60 25.35 29,559.25 17.55 3,169 61.17 52.33
Alkem Laboratories
6,136.85 74,370.03 34.59 12,978.42 9.84 1,811 91.18 56.16
Glenmark Pharmaceuticals
1,649.80 48,348.71 - 12,653.09 6.58 -1,831 96.52 48.98
Biocon
361.50 45,082.53 28.88 15,621.20 35.25 1,298 478.78 47.25

Corporate Action

Technical Indicators

RSI(14)
Neutral
49.25
ATR(14)
Volatile
17.02
STOCH(9,6)
Neutral
44.83
STOCH RSI(14)
Neutral
63.79
MACD(12,26)
Bearish
-1.25
ADX(14)
Weak Trend
17.36
UO(9)
Bearish
44.53
ROC(12)
Uptrend And Accelerating
0.09
WillR(14)
Neutral
-62.53
Bearish
3
Neutral
5
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.